SCHEMBL30689303

SCHEMBL30689303

C=C(Cc1nc(-c2ccc(Oc3ccc(NC)cn3)cc2)no1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 3/20 0.42
▸ MITF O75030 1/20 0.42
▸ NCOA3 Q9Y6Q9 1/20 0.42
▸ LMNA P02545 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ ATM Q13315 2/20 0.41
▸ LTA4H P09960 1/20 0.41
▸ ACACB O00763 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GSTP1 P09211 3/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ FFAR1 O14842 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689438 0.87 LMNA (0.51) TP53MITFNCOA3LMNAMAPT
SCHEMBL30689423 0.86 TP53 (0.41) TP53MITFNCOA3LMNAMAPT
SCHEMBL30689424 0.85 TP53 (0.43) TP53MITFNCOA3LMNAMAPT
SCHEMBL30689302 0.83 FFAR1 (0.49) TP53LMNAMAPTHTTSMN1; SMN2
SCHEMBL30689323 0.82 TP53 (0.42) TP53MITFNCOA3LMNAKMT2A
SCHEMBL30689347 0.81 IP6K1 (0.48) TP53MITFNCOA3LMNAATM
SCHEMBL31528007 0.80 MITF (0.43) TP53MITFNCOA3LMNAKMT2A
SCHEMBL30689419 0.79 FFAR1 (0.53) TP53MITFNCOA3LMNAMEN1
SCHEMBL30689370 0.79 TP53 (0.42) TP53MITFNCOA3LMNAMAPT
SCHEMBL30689328 0.79 FFAR1 (0.43) TP53MITFNCOA3LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback